Anti-hist. / Expectorants/ Mucolytics… Flashcards

1
Q

ANTI-HISTAMINES: FIRST GENERATION
Exs.

A

-ine
Examples: diphenhydramine, promethazine,
chlorpheniramine, meclizine, dimenhydrinate,
hydroxyzine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

-ANTI-HISTAMINES: FIRST GENERATION
MoA

A

Cross the blood-brain barrier so there are sedative effects

-Mechanism of action: Reversible competitive
antagonists of H1 receptors
- May be ineffective at high levels of histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical uses of ANTI-HISTAMINES: FIRST GENERATION

A

 Allergic reactions, rhinitis, urticaria
 Cold medication
 Sleep aid
 Pre-op sedation
 Nausea/vomiting
 Motion sickness, vertigo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

H1- receptors cause

A
  1. Bronchoconstriction
  2. Itching (b/c receptors are activated)
  3. Incr. vascular permeability
  4. Nasal irritation/sneezing/ congestion
  5. Vasodilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ANTI-HISTAMINES: Side effects due to blockade of

A

 Central nervous system histamine receptors
 Muscarinic receptors
α1-adrenergic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ANTI-HISTAMINES: ADVERSE EFFECTS

A

 Sedation
 Blurred vision
 Dry mouth
 Urinary retention
 Headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ANTI-HISTAMINES: SECOND GENERATION
Exs.

A

-ine
1. Loratadine
2. Desloratadine
3. Fexofenadine
4. Cetirizine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

‘ANTI-HISTAMINES: SECOND GENERATION
MoA

A
  • Decreased penetrance into CNS
  • Less sedative effects compared to first generation
    (Don’t cross BBB)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ANTI-HISTAMINES: SECOND GENERATION
Clinical use+ side effects

A

Clinical uses: allergy
Side effects: uncommon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When are COUGH SUPPRESSANTS used + what’s the MoA

A

DONT USE TO SUPPRESS COUGH
- Best to treat underlying cause rather than
cough
- Mechanism of action: Ill-defined effect in
brainstem ‘cough center’
-Gi-linked µ-receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

COUGH SUPPRESSANTS
Exs

A

Opioids: suppress cough in doses below
those required for pain relief
1. Codeine
2. Pholcodeine
3. Morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Codeine is?

A

weak opioid
 Less addiction than morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pholcodeine is? Is it short or long acting?

A

has similar but possibly less
intense adverse effects than codeine;
long-acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Morphine is used for…

A

Palliative care in lung cancer cough
(For analgesia too)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

OPIOD ADVERSE EFFECTS

A

 Constipation  Drowsiness  Dry mouth  Miosis  Nausea/vomiting  Respiratory depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Opioid CI

A

Should be avoided in chronic pulmonary infection
and asthma
- Thickening of mucus and retention
- Risk of respiratory depression

17
Q

COUGH SUPPRESSANTS
Ex.

A

Dextromethorphan: morphine derivative

18
Q

Dextromethorphan MoA
(Doesn’t act like opioid )

A

Binds σ receptors
 Also binds serotonergic receptors and inhibits reuptake of serotonin
—>May cause serotonin syndrome if combined with other serotonergic agents
 Effects mediated via opioid receptors only in excess
- Naloxone can be given for O/D
 Also antagonizes glutamate NMDA receptors at higher therapeutic doses

19
Q

Dextromethorphan AE

A

Uncommon; dizziness, nausea, vomiting,
or GI disturbance
( it’s well tolerated)

20
Q

EXPECTORANT ex. + therapeutic Indication

A

Guaifenesin is the only FDA-approved expectorant

Therapeutic indication: symptomatic relief of acute
productive cough

21
Q

Guaifenesin MoA

A

Mechanism of action
 Increases the volume of respiratory secretions
 Decreases the viscosity of bronchial secretions
 Does not suppress the cough reflex

22
Q

Is Guaifenesin used alone?

A

Used alone or in combination with antihistamines,
cough suppressants, and decongestants

23
Q

DECONGESTANTS exs.

A
  1. Pseudoephedrine
  2. Phenylephrine
24
Q

-Pseudoephedrine MoA

A

a1 adrenergic agonist and release of norepinephrine

-Methamphetamine precursor

25
Pseudoephedrine AE
- not preferred b/c of all the AE CNS stimulation, anxiety, hypertension, urinary retention, tachycardia, nausea/vomiting
26
Phenylephrine MoA
 Selective a1 adrenergic agonist  Less CNS stimulation than pseudoephedrine
27
Classic mucolytic ex.
N-acetyl cysteine used in COPD; cystic fibrosis Evidence of efficacy is poor
28
MUCOLYTICS MoA
 Depolymerizes the mucin glycoprotein oligomers via disulfide bond hydrolysis  Decreases mucus viscosity
29
MUCOLYTICS antidote+ AE
Antidote for paracetamol overdose Side effects: nausea, vomiting, flushing, rash
30
MUCOLYTICS are? + exs.
Secondary polymer network of DNA and F-actin develops in secretions with airway inflammation 1. Peptide mucolytics 2. Hypertonic saline
31
Peptide mucolytics exs.
Dornase alfa (recombinant human DNAse)
32
Dornase alfa MoA + clinical use
Mechanism of action: depolymerizes DNA Used in cystic fibrosis
33
Hypertonic saline (sodium chloride) MoA
Disrupts ionic bonds within the mucus gel Dissociates DNA from mucoproteins allowing natural proteolytic enzymes to digest the mucoprotein